Clinical outcomes of conversion surgery following neoadjuvant chemoimmunotherapy in potentially resectable stage IIIA/IIIB non-small cell lung.

Sci Rep · 2025 · PMC12106633 · PMID 40419636

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

However, when assessing the changes in immune profiles during neoadjuvant treatment, a notable trend emerged.

also in 2,310 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.